Johnson & Johnson (NYSE:JNJ)

100.14
Data as of Jan 30
 -2.24 / -2.19%
Today’s Change
86.09
Today|||52-Week Range
109.49
-4.24%
Year-to-Date
Gilead Sciences' Future in 3 Simple Slides
10:04am / MotleyFool.com
3 reasons why the ECB stimulus matters
Jan 22 / CNNMoney.com
The Golden Age of Dividend Investing Is Dead
9:01am / MotleyFool.com
Bayer Announces Updates to European Label of Xarelto - Analyst Blog
Jan 21 / Zacks.com
Obamacare Hurdles Lowered Expectations, But Has 3 Major Questions Left Unanswered
7:15am / MotleyFool.com
3 Great Stocks for a Volatile Market
Jan 21 / MotleyFool.com
Pharmacyclics Up on Imbruvica Label Expansion in the U.S. - Analyst Blog
Jan 30 / Zacks.com
Healthcare ETFs in Focus on Mixed JNJ Results - ETF News And Commentary
Jan 21 / Zacks.com
Ebola's worst enemy: disease control expert Dr Anthony S Fauci
Jan 30 / FT.com
Young Investors Are Buying the Wrong Stocks
Jan 21 / MotleyFool.com
Frontrunning: January 30
Jan 30 / Investing Channel
Valeant chief Pearson admits 'miscalculation' in Allergan pursuit
Jan 21 / FT.com
ETF Spotlight: Dividend Aristocrat Index
Jan 29 / Benzinga
Why Johnson & Johnson's Stock Could Crater in 2015
Jan 21 / MotleyFool.com
Novartis and J&J back UK biotech working on 30-minute STD test
Jan 29 / FT.com
Stock Market News for January 21, 2015 - Market News
Jan 21 / Zacks.com
Fed stays 'patient' but rate hikes are coming
Jan 28 / CNNMoney.com
Evotec Signs New Deal for Addictive Disorder Therapies - Analyst Blog
Jan 20 / Zacks.com
3 Stocks Boosting The Drugs Industry Higher
Jan 28 / TheStreet.com
Novartis' Cosentyx Approved in Europe for Plaque Psoriasis - Analyst Blog
Jan 20 / Zacks.com
Not Every Company Is Getting Hurt by the Strong U.S. Dollar
Jan 28 / TheStreet.com
Johnson & Johnson Overcomes Threats from Competitors, Delivers Solid Quarterly Result...
Jan 20 / MotleyFool.com
Tighten Those Chin Straps Folks Because Here Comes a Rapid Unscheduled Disassembly (R...
Jan 27 / Investing Channel
Delta takes flight as earnings soar ahead of forecasts
Jan 20 / FT.com
Market Wrap: Futures Tumble On Spike Of "Strong Dollar" Earnings Disappointments And ...
Jan 27 / Investing Channel
J&J Beats on Q4 Earnings, Revenues Hit by Currency - Analyst Blog
Jan 20 / Zacks.com
How to Tell if a Dividend Is Safe
Jan 26 / MotleyFool.com
The Dow Drops as Earnings, Politics Weigh on Markets
Jan 20 / MotleyFool.com
CytRx Candidate Encourages in Soft Tissue Sarcoma Study - Analyst Blog
Jan 26 / Zacks.com
Stock Market News for January 20, 2015 - Market News
Jan 20 / Zacks.com
5 Things Johnson & Johnson's Management Wants You to Know
Jan 26 / MotleyFool.com
IMF Cuts, Q4 Earnings Mixed - Ahead of Wall Street
Jan 20 / Zacks.com
AstraZeneca's Regulatory Filing for Lesinurad Accepted - Analyst Blog
Jan 26 / Zacks.com
J&J (JNJ) Beats on 4Q Earnings but Misses on Revenues - Tale of the Tape
Jan 20 / Zacks.com
5 Cant-Miss Reasons Why Celgene Corporation Could Soar
Jan 26 / MotleyFool.com
Stocks: 6 things to know before the open
Jan 20 / CNNMoney.com
Minerva Neurosciences Gains on Positive Data on MIN-202 - Analyst Blog
Jan 23 / Zacks.com
Will Pharmaceutical Segment Drive J&J Q4 Earnings Again? - Analyst Blog
Jan 19 / Zacks.com
Dow 30 Stock Roundup: AmEx, UnitedHealth Beat, IBM Earnings Fall Y/Y - Analyst Blog
Jan 23 / Zacks.com
Q4 Earnings Take a Breather for MLK Day - Ahead of Wall Street
Jan 19 / Zacks.com
Investors Sold Johnson & Johnson For All the Wrong Reasons
Jan 23 / MotleyFool.com
3 Big Pharma Stocks With More Free Cash Flow Than Gilead Sciences Inc.
Jan 18 / MotleyFool.com
Company Notes Digest 1.23.15
Jan 23 / StockTwits
In Case You Missed it, Diabetics May Have a New Worry From an Unlikely Source
Jan 17 / MotleyFool.com
GSK ships Ebola vaccine to west Africa
Jan 23 / FT.com
J&J receives b,100m EU injection for Ebola vaccine development
Jan 16 / FT.com
Novartis' Psoriasis Drug Cosentyx Gets FDA Approval - Analyst Blog
Jan 22 / Zacks.com
Are healthcare stocks good for your wealth?
Jan 14 / FT.com
Natus Medical's a Strong Buy on Expanding Product Portfolio - Analyst Blog
Jan 22 / Zacks.com
Fresh round of M&A sweeps pharma sector
Jan 12 / FT.com

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.